Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome ...

The U.S. Food and Drug Administration (FDA) on Wednesday initiated an immediate review of clinical trials that involved sending Americans’ living cells to China and other foreign adversaries for ...

Imagine writing a letter of life-and-death importance and trying to mail it only to discover that you have the wrong address, the wrong envelope and no way to buy a stamp. Robert Langer of the ...

OBERLIN, Ohio — Synapse Biomedical, a medical device company based in Oberlin, received FDA premarket approval Wednesday for a breathing device that allows patients with spinal cord injuries to ...

Most organizations and companies have two main goals—fulfill a purpose and generate profit. In some cases, profit is prioritized over purpose. However, for researchers at Texas A&M University and ...

The iLet Bionic Pancreas, which automates insulin delivery to manage the chronic disease, was invented in Ed Damiano’s biomedical engineering lab—and inspired by his son A bionic pancreas—a wearable, ...

Natural rubber latex (NRL), a colloidal dispersion predominantly derived from Hevea brasiliensis, has emerged as a promising biocompatible medium for drug delivery and various biomedical applications.

Dr. Balakrishna Haridas (second, from right) and his team of researchers will continue their work and development of pediatric devices thanks to a $7.4 million grant renewal from the U.S. Food and ...